# Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

> **NCT00770445** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 121 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone and insulin
- **DRUG:** Pioglitazone and metformin and insulin
- **DRUG:** Metformin and insulin

## Key facts

- **NCT ID:** NCT00770445
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2010-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770445, "Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00770445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*